Yu Chen Jiao
Technik-/Wissenschafts-/F&E-Leiter bei GENETRON HOLDINGS LIMITED
Aktive Positionen von Yu Chen Jiao
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| GENETRON HOLDINGS LIMITED | Technik-/Wissenschafts-/F&E-Leiter | 01.08.2017 | - |
Beijing Genetron Health Gene Technology Co., Ltd.
 Beijing Genetron Health Gene Technology Co., Ltd. Information Technology ServicesTechnology Services Beijing Genetron Health Gene Technology Co. Ltd. provides software development services. It also engages in the import, export and sale of medical equipment. The company was founded on May 7, 2015 and is headquartered in Beijing, China. | Direktor/Vorstandsmitglied | - | - |
| Chinese Academy of Medical Sciences | Corporate Officer/Principal | 01.12.2013 | - |
Karriereverlauf von Yu Chen Jiao
Ausbildung von Yu Chen Jiao
| Peking Union Medical College | Doctorate Degree |
| The Johns Hopkins University | Doctorate Degree |
Statistik
International
| China | 5 |
| Vereinigte Staaten | 2 |
Operativ
| Doctorate Degree | 2 |
| Director/Board Member | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
Sektoral
| Consumer Services | 4 |
| Technology Services | 2 |
| Health Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Beijing Genetron Health Gene Technology Co., Ltd.
Beijing Genetron Health Gene Technology Co., Ltd. Information Technology ServicesTechnology Services Beijing Genetron Health Gene Technology Co. Ltd. provides software development services. It also engages in the import, export and sale of medical equipment. The company was founded on May 7, 2015 and is headquartered in Beijing, China. | Technology Services |
Genetron Holdings Ltd.
 Genetron Holdings Ltd. Medical/Nursing ServicesHealth Services Genetron Holdings, Ltd. engages in precision oncology. It provides cancer molecular profiling by using technologies in molecular biology and data science to transform cancer treatment. It products and services include diagnosis and monitoring through both LDT and IVD products. Its LDT portfolio consists of both specifically designed focused and comprehensive gene panel testing services. It also develops liver cancer early screening products. The company was founded by Si Zhen Wang, Hai Yan, and Wei Wu He in 2015 and is headquartered in Beijing, China. | Health Services |
- Börse
- Insiders
- Yu Chen Jiao
- Erfahrung
